Implementation of Magnetic Resonance Imaging-Guided Radiation Therapy in Routine Care: Opportunities and Challenges in the United States
Hehakaya, Charisma; Sharma, Ankur M; van der Voort Van Zijp, Jochem R N; Grobbee, Diederick E; Verkooijen, Helena M; Izaguirre, Enrique W; Moors, Ellen H M
(2022) Advances in Radiation Oncology, volume 7, issue 5, pp. 1 - 12
(Article)
Abstract
Purpose: Magnetic resonance image (MRI)-guided radiation therapy with the 1.5 Tesla magnetic resonance linear accelerator (MR-Linac) is a rapidly evolving and emerging treatment. The MR-Linac literature mainly focused on clinical and technological factors in technology implementation, but it is relatively silent on health care system-related factors. Consequently, there is a
... read more
lack of understanding of opportunities and barriers in implementing the MR-Linac from a health care system perspective. This study addresses this gap with a case study of the US health care system. Methods and Materials: An exploratory, qualitative research design was used. Data collection consisted of 23 semistructured interviews ranging from clinical experts at the radiation therapy and radiology department to insurance commissioners in 7 US hospitals. Analysis of opportunities and barriers was guided by the Nonadoption, Abandonment, Scale-up, Spread and Sustainability framework for new medical technologies in health care organizations. Results: Opportunities included high-precision MR-guidance during radiation therapy with potential continued technical advances and better patient outcomes. MR-Linac also offers opportunities for research, professional, and economic development. Barriers included the lack of empirical evidence of clinical effectiveness, technological complexity, and large staffing and structural investments. Furthermore, the presence of patients with disadvantaged socioeconomic background, and the lack of appropriate reimbursement as well as regulatory conditions can hinder technology implementation. Conclusions: Our study confirms the current literature on implementing the MR-Linac, but also reveals additional challenges for the US health care system. Alongside the well-known clinical and technical factors, also professional, socioeconomic, market, and governing influences affect technology implementation. These findings highlight new connections to facilitate technology uptake and provide a richer start to understanding its long-term effect.
show less
Download/Full Text
Keywords: Access, Health technology-assessment, Innovations, Oncology, Product development, Promises, Radiotherapy, Oncology, Radiology Nuclear Medicine and imaging
ISSN: 2452-1094
Publisher: Elsevier
Note: Funding Information: Sources of support: This project is partly funded by “clinical introduction online and real-time MRI-guided prostate cancer radiation therapy” (project number 104006004) funded by the Netherlands Organization for Health Research and Development (ZonMw) via Innovative Medical Devices Initiative for Technology for Sustainable Healthcare, author AS professional educational allowance and Elekta AB (Stockholm, Sweden). Several MR-Linac scientific projects at the Division of Imaging and Oncology of University Medical Center Utrecht have been partly funded Elekta AB (Stockholm, Sweden) and Philips Medical Systems (Best, The Netherlands). The funding bodies have had no part in the study design, data collection and analysis, and writing of this manuscript. Funding Information: Sources of support: This project is partly funded by “clinical introduction online and real-time MRI-guided prostate cancer radiation therapy” (project number 104006004) funded by the Netherlands Organization for Health Research and Development (ZonMw) via Innovative Medical Devices Initiative for Technology for Sustainable Healthcare, author AS professional educational allowance and Elekta AB (Stockholm, Sweden). Several MR-Linac scientific projects at the Division of Imaging and Oncology of University Medical Center Utrecht have been partly funded Elekta AB (Stockholm, Sweden) and Philips Medical Systems (Best, The Netherlands). The funding bodies have had no part in the study design, data collection and analysis, and writing of this manuscript. Disclosures: Charisma Hehakaya reports financial support was provided by Elekta AB. Jochem van der Voort van Zijp reports a relationship with Elekta AB that includes: funding grants and speaking and lecture fees. Helena M. Verkooijen reports a relationship with Elekta AB that includes: funding grants. Funding Information: Disclosures: Charisma Hehakaya reports financial support was provided by Elekta AB. Jochem van der Voort van Zijp reports a relationship with Elekta AB that includes: funding grants and speaking and lecture fees. Helena M. Verkooijen reports a relationship with Elekta AB that includes: funding grants. Publisher Copyright: © 2022 The Authors
(Peer reviewed)
See more statistics about this item